Oslogynekologene AS
Score · fiscal year 2025
29of 100
How to read this: the company is ahead of 15 % of companies in the Morning class Micro in the same sector in 2025. What does this mean?
Rank in the Morning class Micro: 1,270 of 1,498 · What are Morning company classes?
Place in the whole sector: 1,740 of 2,037 · Helse og omsorg
Profile
Beaver · Builder
Lower profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 22 and solidity 16 out of 100 among companies in the Morning class Micro in the same sector in 2025. Methodology
Against the sector
Oslogynekologene AS is 21 points below the median for companies in the Morning class Micro in the same sector in 2025.
Median score 50 among 1,494 companies.
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 7 MNOK | 3 MNOK |
| Operating margin | – | 7.8% |
| Profit margin | 0.1% | 7.8% |
| Return on assets | 0.2% | 16.9% |
| Equity ratio | 8.4% | 46.1% |
| Debt-to-equity | 10.93 | 0.93 |
| Current ratio | 0.97 | 1.58 |
| Revenue growth | 7.8% | 3.2% |
The median and “ahead of” refer to companies in the Morning class Micro in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 29, Oslogynekologene AS does better than 15% of companies in the Morning class Micro in the same sector (1,498 companies) in 2025.
Score 2023–2025
- Oslogynekologene AS
- Median: companies in the Morning class Micro in the same sector
Oslogynekologene AS has a score of 29 for 2025, rank 1,740 of 2,037 in the sector.
Strongest: Growth: percentile 68 against peers, revenue growth 7.8% against a median of 3.2%.
Weakest: Solidity: percentile 16 against peers, equity ratio 8.4% against a median of 46.1%. Profitability: percentile 22 against peers.
Worth a closer look
- The equity ratio is very low. Could the company absorb a bad year, and does it need more equity? Based on: equity ratio 8.4% (median 46.1%).
- Consider strengthening liquidity: current liabilities are 1.0 times current assets. Based on: current ratio 0.97 (median 1.58).
- What lies behind weak solidity, and will it last?
- What lies behind weak profitability, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
Oslogynekologene AS had an operating margin of – and an equity ratio of 8.4% in 2025, and ranks 1,740 of 2,037 in Helse og omsorg.
No large changes in the key figures from 2024 to 2025.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 0 MNOK and 0 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 0 MNOK |
| EV/EBIT | 8.0 | missing |
| P/B | 1.0 | 0 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
The equity ratio is very low. Could the company absorb a bad year, and does it need more equity?
Based on: Equity ratio 8.4% (median 46.1%).
- watch
Consider strengthening liquidity: current liabilities are 1.0 times current assets.
Based on: Current ratio 0.97 (median 1.58).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.0% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of −10.4%. Based on the 6 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 22 | weight 30% |
|---|---|---|
| Solidity | 16 | weight 25% |
| Liquidity | 23 | weight 15% |
| Growth | 68 | weight 15% |
| Consistency | 32 | weight 15% |
Durability: 25 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Oslogynekologene AS?
The operating margin was – in 2025, against a median of 7.8% among companies in the Morning class Micro in the same sector. Return on assets was 0.2%.
How solid is Oslogynekologene AS?
The equity ratio was 8.4% in 2025 (median 46.1%). Debt-to-equity was 10.93 (median 0.93).
What is the liquidity of Oslogynekologene AS like?
The current ratio was 0.97 in 2025 (median 1.58). Current assets did not cover current liabilities.
How does Oslogynekologene AS compare in Helse og omsorg?
Oslogynekologene AS ranks 1,740 of 2,037 in Helse og omsorg for 2025. Among companies in the Morning class Micro it is number 1,270 of 1,498. Revenue changed by 7.8% from the year before.
From the Central Coordinating Register
- Org. no.
- 914503930
- Legal form
- AS
- Sector
- Helse og omsorg (86.221)
- Morning company class
- Micro
- Employees
- 0–4 (not registered)
- Founded
- 31 October 2014 12 years in operation
- Share capital
- 0.10 MNOK
- Business address
- Kirkeveien 64A, 0364 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Audit
- Audit opted out from 8 November 2025
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 2 November 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 31 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 20 | 25 | 29 | |
| Rank | 1,728 | 1,748 | 1,740 | |
| Operating margin | 0.0% | −0.1% | – | |
| Return on assets | 0.0% | 0.0% | 0.2% | |
| Equity ratio | 8.7% | 9.0% | 8.4% | |
| Current ratio | 0.99 | 1.02 | 0.97 | |
| Revenue growth | – | 3.4% | 7.8% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 5.8 MNOK | 6.0 MNOK | 6.5 MNOK |
| Operating profit | 0.0 MNOK | 0.0 MNOK | – |
| Profit before tax | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Net profit | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Financial expenses | – | – | 0.0 MNOK |
| Total assets | 1.5 MNOK | 1.4 MNOK | 1.6 MNOK |
| Current assets | 1.4 MNOK | 1.3 MNOK | 1.4 MNOK |
| Equity | 0.1 MNOK | 0.1 MNOK | 0.1 MNOK |
| Retained earnings | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Total liabilities | 1.4 MNOK | 1.3 MNOK | 1.4 MNOK |
| Current liabilities | 1.4 MNOK | 1.3 MNOK | 1.4 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 31 October 2026, accounts id 6476877.
Further
Similar companies
- Meeno AS index 29, rank 1,737 · compare
- Markedet Legesenter Administrasjon AS index 29, rank 1,738 · compare
- Vestsiden Legesenter AS index 29, rank 1,739 · compare
- Tmd-Klinikken AS index 29, rank 1,741 · compare
- Eip AS index 29, rank 1,742 · compare